| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $798.2M | $705.8M | $631.6M |
| YoY Revenue Growth % | +13.1% | +11.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $592.2M | $539.1M | $486.1M |
| Operating Margin % | 74.2% | 76.4% | 77.0% |
| Net Income (GAAP) | $481.4M | $454.0M | $405.6M |
| EBITDA (Normalized) | $620.9M | $564.5M | $508.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $545.9M | $490.7M | $418.3M |
| Capital Expenditures (CapEx) | $35.9M | $31.8M | $28.4M |
| Free Cash Flow (FCF) | $510.0M | $458.9M | $389.9M |
| FCF Margin % | 63.9% | 65.0% | 61.7% |
| Return on Invested Capital (ROIC %) | 33.7% | 52.3% | 5.1% |
| Cash & Short-Term Equivalents | $144.8M | $369.8M | — |
| Total Debt (Short + Long Term) | $74.0M | $52.0M | $2.91B |
| Total Stockholders' Equity | $1.46B | $1.13B | $5.97B |